Found: 5
Select item for more details and to access through your institution.
Polθ Inhibitor (ART558) Demonstrates a Synthetic Lethal Effect with PARP and RAD52 Inhibitors in Glioblastoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 17, p. 9134, doi. 10.3390/ijms25179134
- By:
- Publication type:
- Article
Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 319, doi. 10.3390/ijms24010319
- By:
- Publication type:
- Article
Histone Deacetylases (HDAC) Inhibitor—Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor.
- Published in:
- Genes, 2023, v. 14, n. 6, p. 1295, doi. 10.3390/genes14061295
- By:
- Publication type:
- Article
Synthetic Lethality Targeting Polθ.
- Published in:
- Genes, 2022, v. 13, n. 6, p. 1101, doi. 10.3390/genes13061101
- By:
- Publication type:
- Article
Class I HDAC Inhibition Leads to a Downregulation of FANCD2 and RAD51, and the Eradication of Glioblastoma Cells.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 9, p. 1315, doi. 10.3390/jpm13091315
- By:
- Publication type:
- Article